Cited 2 time in
Structural insights into the transcriptional regulator NalC, a key component of the MexAB-OprM efflux pump system, from Pseudomonas aeruginosa
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jeong, Kang Hwa | - |
| dc.contributor.author | Ko, Ji Hyuk | - |
| dc.contributor.author | Son, Su Bean | - |
| dc.contributor.author | Lee, Jae Young | - |
| dc.date.accessioned | 2024-08-08T08:30:32Z | - |
| dc.date.available | 2024-08-08T08:30:32Z | - |
| dc.date.issued | 2023-10 | - |
| dc.identifier.issn | 0006-291X | - |
| dc.identifier.issn | 1090-2104 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/20321 | - |
| dc.description.abstract | Pseudomonas aeruginosa is an opportunistic pathogen with significant public health implications due to its multi-drug resistance (MDR). Among the mechanisms that mediate MDR, the NalC protein, a member of the TetR family of transcriptional regulators, modulates the mexAB-oprM operon, thus facilitating the efflux pump system. The resistance-nodulation-division (RND) family of multidrug efflux pumps plays a crucial role in expelling a broad spectrum of antimicrobial compounds, serving as a key adaptive mechanism. Structural analyses revealed that NalC adopts a modular architecture consisting of distinct domains involved in ligand recognition and transcriptional regulation. The N-terminal domain of NalC contains a DNA-binding helix-turn-helix motif, which interacts with specific DNA sequences in the PA3720-armR operon region. This interaction initiates the transcriptional activation of the efflux pump system. On the other hand, the C-terminal domain of NalC exhibits a highly dynamic structure and is implicated in ligand sensing and signal transduction. Our findings suggest potential binding sites for small molecules that could act as allosteric modulators, thereby providing new avenues for the development of therapeutic strategies targeting MDR Pseudomonas aeruginosa. © 2023 Elsevier Inc. | - |
| dc.format.extent | 5 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier B.V. | - |
| dc.title | Structural insights into the transcriptional regulator NalC, a key component of the MexAB-OprM efflux pump system, from Pseudomonas aeruginosa | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.bbrc.2023.08.065 | - |
| dc.identifier.scopusid | 2-s2.0-85169511030 | - |
| dc.identifier.wosid | 001070671700001 | - |
| dc.identifier.bibliographicCitation | Biochemical and Biophysical Research Communications, v.679, pp 47 - 51 | - |
| dc.citation.title | Biochemical and Biophysical Research Communications | - |
| dc.citation.volume | 679 | - |
| dc.citation.startPage | 47 | - |
| dc.citation.endPage | 51 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Biophysics | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Biophysics | - |
| dc.subject.keywordPlus | TET REPRESSOR | - |
| dc.subject.keywordPlus | RESISTANCE | - |
| dc.subject.keywordPlus | MECHANISMS | - |
| dc.subject.keywordPlus | COMPLEX | - |
| dc.subject.keywordPlus | MODEL | - |
| dc.subject.keywordAuthor | Crystal structure | - |
| dc.subject.keywordAuthor | Multi-drug efflux system | - |
| dc.subject.keywordAuthor | NalC | - |
| dc.subject.keywordAuthor | TetR-type transcriptional factor | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
